Chlamydial virulence determinants in atherogenesis: The role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage- lipoprotein interactions

Journal of Infectious Diseases

Volumn 181, Issue 6 SUPPL. 3, 2000, Pages

  Kalayoglu, Murat V ^a   Indrawati, ^a   Morrison, Richard P ^b   Morrison, Sandra G ^b   Yuan, Ying ^c   Byrne, Gerald I ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 60; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; FOAM CELL; MONONUCLEAR PHAGOCYTE; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; VIRULENCE;

EID: 0034049837     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315619     Document Type: Conference Paper

References (42)

1. 1. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
2. 2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-6.
3. 3. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92:6911-4.
4. 4. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82:158-61.
5. 5. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997; 176:292-5.
6. 6. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633-6.
7. 7. Moazed TC, Kuo C, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997; 175: 883-90.
8. 8. Rund S, Lindner B, Brade H, Holst O. Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2. J Biol Chem 1999; 274:16819-24.
9. 9. LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol 1999; 7:64-71.
10. 10. Kol A, Bourcier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, und macrophages. J Clin Invest 1999; 103:571-7.
11. 11. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87:1130-4.
12. 12. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 1998; 98: 300-7.
13. 13. Libby P, Clinton S. The role of macrophages in atherogenesis. Curr Opin Lipidol 1993; 4:355-63.
14. 14. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977; 46:897-930.
15. 15. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52:223-61.
16. 16. Brown MS, Goldstein JL. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci USA 1979; 76:3330-7.
17. 17. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998; 177:725-9.
18. 18. Kalayoglu MV, Miranpuri GS, Golenbock DT, Byrne GI. Characterization of low density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae. Microb Infect 1999; 1:409-18.
19. 19. Hackstadt T, Scidmore MA, Rockey DD. Lipid metabolism in Chlamydia trachomatis infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci USA 1995; 92: 4877-81.
20. 20. Hackstadt T, Rockey DD, Heinzen RA, Seidmore MA. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. Embo J 1996; 15:964-77.
21. 21. Scidmore MA, Fischer ER. Hackstadt T. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol 1996; 134:363-74.
22. 22. Wylie JL, Hatch GM, McClarty G. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol 1997; 179: 7233-42.
23. 23. Liscum L, Munn NJ. Intracellular cholesterol transport. Biochim Biophys Acta 1999; 1438:19-37.
24. 24. Brooks-Wilson A, Marcil M, Clee SM. et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-45.
25. 25. Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22:352-5.
26. 26. Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22: 347-51.
27. 26a. Gura T. Gene linked to faulty cholesterol transport. Science 1999; 285:814-5.
28. 27. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998; 66:5067-72.
29. 28. Qureshi N, Takayama K. Structure and function of lipid A. In: Miglewski BH, Clark VL, eds. The bacteria. A treatise on structure and function. Vol XI. San Diego: Academic Press, 1990:319-38.
30. 29. Ingalls RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenbock DT. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 1995; 63:3125-30.
31. 30. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95:1062-71.
32. 31. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272:20963-6.
33. 32. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 1997; 272:3520-6.
34. 33. Raitakari OT, Pitkanen OP, Lehtimaki T, et al. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am Coll Cardiol 1997; 30:97-102.
35. 34. Juul K, Nielsen LB, Munkholm K, Stender S, Nordestgaard BG. Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation 1996; 94:1698-704.
36. 35. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-16.
37. 36. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 1999; 180:780-90.
38. 37. Mayr M, Metzler B, Kiechl S, et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999; 99:1560-6.
39. 38. Garduno R, Faulkner G, Trevors M, Vats N, Huffman P. Immunolocalization of Hsp60 in Legionella pneumophila. J Bacteriol 1998; 180:505-13.
40. 39. Garduno R, Garduno E, Hoffman P. Surface-associated Hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model. Infect Immun 1998; 66:4602-10.
41. 40. Retzlaff C, Yamamoto Y, Okubo S, Huffman P, Friedman H, Klein T. Legionella pneumophila heat shock protein-induced increase of interleukin 1 beta mRNA involves protein kinase C signalling in macrophages. Immunology 1996; 89:281-8.
42. 41. Hoffman JA, Kafatos FC, Janeway CA Jr, Ezekowitz RAB. Pylogenetic perspectives in innate immunity. Science 1999; 284:1313-8.